Volume 37, Issue 8, 2022-8-1, Pages A1-1668

Articles in this issue:

1. Editorial Board

• Pages A1-A1.
• PDF

2. Masthead

• Pages A2-A2.
• PDF

3. Table of Contents

• Pages A3-A11.
• PDF

4. The 2021 American Association of Hip and Knee Surgeons Annual Meeting Proceedings to be Published Online; Open to All

• Pages 1417-1417.
• Springer, Bryan D., MD, and Mont, Michael Albert, MD.
• PDF

5. Symposia From the 2021 American Association of Hip and Knee Surgeons in August Issue

• Pages 1418-1418.
• Springer, Bryan D., MD, and Mont, Michael A., MD.
• PDF

6. Total Hip Arthroplasty Itself May Be a Parachute, but Everything Else We Do is Not

• Pages 1419-1420.
• Browne, James A., MD.
• PDF

7. Caring for Diverse and High-Risk Patients: Surgeon, Health System, and Patient Integration

• Pages 1421-1425.
• Suleiman, Linda I., MD, Tucker, Kimberly, MD, Ihekweazu, Ugo, MD, Huddleston, James I., MD, and Cohen-Rosenblum, Anna R., MD, MSc.
• PDF

8. Practice Management Strategies Among Current Members of the American Association of Hip and Knee Surgeons

• Pages 1426-1430.e3.
• Lieberman, Jay R., MD, Chen, Antonia F., MD, MBA, and Iorio, Richard, MD.
• PDF

9. How Should Antibiotics Be Used in Primary and Revision Hip and Knee Arthroplasty? An Introduction

• Pages 1431-1431.
• Clarke, Henry D., MD.
• PDF

10. Preoperative Prophylactic Antibiotics in Total Hip and Knee Arthroplasty: What, When, and How

• Pages 1432-1434.
• Spangehl, Mark, MD, FRCS(C).
• PDF

11. When and How Should I Use Antibiotic Cement in Primary and Revision Joint Arthroplasty?

• Pages 1435-1437.
• Bingham, Joshua, MD.
• PDF

12. Irrigation Solutions and Antibiotic Powders: Should I Use Them in Primary and Revision Total Joint Arthroplasty?

• Pages 1438-1440.
• Springer, Bryan D., MD.
• PDF

13. Is There a Role for Extended Postoperative Oral Antibiotics in Primary Total Joint Arthroplasty High-Risk Individuals After Surgery for Periprosthetic Joint Infection?

• Pages 1441-1442.
• Higuera, Carlos A., MD.
• PDF

14. The Changing Economic Value and Leverage of Arthroplasty Surgeons

• Pages 1443-1447.
• Iorio, Richard, MD.
• PDF

15. The National Trend in Arthroplasty Surgery Location and the Economic Impact on Surgeons, Hospitals and ASCs

• Pages 1448-1451.
• Haas, Derek A., MBA, Zhang, Xiaoran, MA, Barnes, C. Lowry, MD, and Iorio, Richard R., MD.
• PDF

16. Identifying and Creating Value for Employed Arthroplasty Surgeons in an Era of Decreasing Reimbursement

• Pages 1452-1454.
• Gold, Peter A., MD, Krueger, Chad A., MD, and Barnes, C. Lowry, MD.
• PDF

17. How the Shift in Arthroplasty Surgery Location Impacts the Relationship of Private Surgeons, Hospitals, and Ambulatory Surgery Centers

• Pages 1455-1458.
• Arshi, Armin, MD, Wellens, Bryan, MBA, and Krueger, Chad A., MD.
• PDF

18. The Inpatient Only Rule, Alternative Payment Models, and the Relative Value Update Committee Reimbursement and Coding Changes: What Do They Mean?

• Pages 1459-1461.
• Bosco, Joseph A., MD.
• PDF

19. Introduction: Occupational Hazards to the Joint Replacement Surgeon

• Pages 1462-1463.
• Canoles, Haley G., DO, and Vigdorchik, Jonathan M., MD.
• PDF

20. Occupational Hazards to the Joint Replacement Surgeon: Radiation Exposure

• Pages 1464-1469.
• Daryoush, Joshua R., MD, Lancaster, Alex J., MD, Frandsen, Jeffrey J., MD, and Gililland, Jeremy M., MD.
• PDF

21. Occupational Hazards of Orthopedic Surgery Exposures: Infection, Smoke, and Noise

• Pages 1470-1473.
• Kugelman, David, MD, Weppler, Campbell G., Warren, Cooper F., and Lajam, Claudette M., MD.
• PDF

22. Repetitive Musculoskeletal Injuries: A Survey of Female Adult Reconstruction Surgeons

• Pages 1474-1477.e6.
• Cohen-Rosenblum, Anna R., MD, MSc, Varady, Nathan H., SB, Leonovicz, Olivia, BS, and Chen, Antonia F., MD, MBA.
• PDF

23. Occupational Hazards to the Joint Replacement Surgeon: How Can Technology Help Prevent Injury?

• Pages 1478-1481.
• Canoles, Haley G., DO, and Vigdorchik, Jonathan M., MD.
• PDF

24. 2021 AAHKS Symposium: The Painful Total Hip Arthroplasty: “Looks Good but Feels Bad”

• Pages 1482-1482.
• Meneghini, R. Michael, MD.
• PDF

25. Metal Articulations as a Source of Total Hip Arthroplasty Pain

• Pages 1483-1487.
• Kwon, Young-Min, MD, PhD, and Klemt, Christian, PhD.
• PDF

26. Diagnosis and Treatment of Culture-Negative Periprosthetic Joint Infection

• Pages 1488-1493.
• Goh, Graham S., MD, and Parvizi, Javad, MD, FRCS.
• PDF

27. Diagnosis and Detection of Subtle Aseptic Loosening in Total Hip Arthroplasty

• Pages 1494-1500.
• Anil, Utkarsh, MD, Singh, Vivek, MD, MPH, and Schwarzkopf, Ran, MD, MSc.
• PDF

28. Diagnosis and Treatment of Musculotendinous Deficiencies of the Hip

• Pages 1501-1504.
• Deckard, Evan R., BSE, and Meneghini, R. Michael, MD.
• PDF

29. Association of Rurality and Neighborhood Level Socioeconomic Deprivation with Perioperative Health Status in Total Joint Arthroplasty Patients: Analysis from a Large, Tertiary Care Hospital

• Pages 1505-1513.
• Kamath, Celia C., PhD, O’Byrne, Thomas J., MAS, Lewallen, David G., MD, Berry, Daniel J., MD, and Maradit Kremers, Hilal, MD.
• PDF

30. Price Transparency for Primary Hip & Knee Arthroplasty: An Overview of the Top 50 US News and World Report Orthopedic Hospitals

• Pages 1514-1519.
• Cale, John B., MD, Stambough, Jeffrey B., MD, Mears, Simon C., MD, PhD, Hutchinson, Johnny D., BA, Barnes, C. Lowry, MD, and Stronach, Benjamin M., MS, MD.
• PDF

31. Presence of a Posterior Wall Sign in the Treatment of Femoroacetabular Impingement Syndrome: A Matched Comparative Cohort Analysis at Minimum 2-Year Follow-Up

• Pages 1520-1525.
• Sivasundaram, Lakshmanan, MD, Rice, Morgan W., BS, Hevesi, Mario, MD, PhD, Ephron, Christopher G., BS, and Nho, Shane J., MD, MS.
• PDF

32. Adverse Events Associated With Robotic-Assisted Joint Arthroplasty: An Analysis of the US Food and Drug Administration MAUDE Database

• Pages 1526-1533.
• Pagani, Nicholas R., MD, Menendez, Mariano E., MD, Moverman, Michael A., MD, Puzzitiello, Richard N., MD, and Gordon, Matthew R., MD.
• PDF

33. Use of a Smart-Phone Mobile Application is Associated With Improved Compliance and Reduced Length of Stay in Patients Undergoing Primary Total Joint Arthroplasty of the Hip and Knee

• Pages 1534-1540.
• Abdeen, Ayesha, MD, FRCS(C), Monárrez, Rubén, MD, Drew, Jacob M., MD, and Kennedy, Kevin F., MS.
• PDF

34. Complement C3-α and C3-β Levels in Synovial Fluid But Not in Blood Correlate With the Severity of Osteoarthritis Research Society International Histopathological Grades in Primary Knee Osteoarthritis

• Pages 1541-1548.e1.
• Cheng, Tzu Hsuan, MD, Zeng, Jianying, MD, Dehghani, Amir, MD, Dimaculangan, Dennis, MD, Zhang, Ming, MD, PhD, and Maheshwari, Aditya V., MD.
• PDF

35. Liposomal Bupivacaine in Adductor Canal Blocks Before Total Knee Arthroplasty Leads to Improved Postoperative Outcomes: A Randomized Controlled Trial

• Pages 1549-1556.
• Malige, Ajith, MD, Pellegrino, Anna N., MD, Kunkle, Kelcei, Konopitski, Andrew K., MD, Brogle, Patrick J., MD, and Nwachuku, Chinenye O., MD.
• PDF

36. Patient Acceptable Symptom State for the Forgotten Joint Score in Primary Total Knee Arthroplasty

• Pages 1557-1561.
• Singh, Vivek, MD, MPH, Fiedler, Benjamin, BA, Huang, Shengnan, MS, Oh, Cheongeun, PhD, Karia, Raj J., MPH, and Schwarzkopf, Ran, MD, MSc.
• PDF

37. Navigated and Robot-Assisted Technology in Total Knee Arthroplasty: Do Outcome Differences Achieve Minimal Clinically Important Difference?

• Pages 1562-1569.
• Arshi, Armin, MD, Sekimura, Troy, MD, Kelley, Benjamin V., MD, Zeegen, Erik N., MD, Lonner, Jess H., MD, and Stavrakis, Alexandra I., MD.
• PDF

38. Modular Metal-Backed Tibial Components Provide Minimal Mid-Term Survivorship Benefits Despite Increased Cost and Frequency of Use: A Retrospective Review of the American Joint Replacement Registry Database

• Pages 1570-1574.e1.
• Kelley, Benjamin, MD, Mullen, Kyle, MPH, De, Ayushmita, PhD, and Sassoon, Adam, MS, MD.
• PDF

39. Psoriasis and Post-Surgical Infections in Primary Total Knee Arthroplasty: An Analysis of 10,727 Patients

• Pages 1575-1578.
• Gold, Peter A., MD, Garbarino, Luke J., MD, Ramkumar, Prem N., MD, MBA, Anis, Hiba, MD, Sodhi, Nipun, MD, Matuszak, Sean J., BS, and Mont, Michael A., MD.
• PDF

40. Minimum 5-Year Outcomes of a Multicenter, Prospective, Randomized Control Trial Assessing Clinical and Radiological Outcomes of Patient-Specific Instrumentation in Total Knee Arthroplasty

• Pages 1579-1585.
• Hampton, Matthew J., FRCS (Tr&Orth), Blakey, Caroline M., FRCS (Tr&Orth), Anderson, Alex A., FRCS (Tr&Orth), Tomouk, Wassim M., FRCS (Tr&Orth), Buckley, Simon C., FRCS (Tr&Orth), Hamer, Andrew J., FRCS (Tr&Orth), and Sutton, Paul M., FRCS (Tr&Orth).
• PDF

41. Eighteen-Year Outcome of an Uncemented "Meniscal Bearing", Cruciate-Retaining Total Knee System

• Pages 1586-1593.
• Puijk, Raymond, MD, Rassir, Rachid, MD, Sierevelt, Inger N., MSc, Vergroesen, Diederik A., MD, de Jong, Tjitte, MD, and Nolte, Peter A., MD, PhD.
• PDF

42. Ask Patients What They Expect! A Survey Among Patients Awaiting Total Hip Arthroplasty in Germany

• Pages 1594-1601.e4.
• Lützner, Cornelia, PhD, Postler, Anne E., MD, Druschke, Diana, Riedel, Roman, Günther, Klaus-Peter, MD, and Lange, Toni, PhD.
• PDF

43. A Comparison of Component Positioning Between Fluoroscopy-Assisted and Robotic-Assisted Total Hip Arthroplasty

• Pages 1602-1605.e3.
• Stewart, Nathaniel J., MD, Stewart, James L., BS, and Brisbin, Abra, PhD.
• PDF

44. Survivorship and Outcomes of Femoral Neck Preserving Stems in Primary Total Hip Arthroplasty

• Pages 1606-1611.
• Reddy, Gireesh B., MD, Haziza, Sagie, BA, Constantinescu, David S., MD, Pagan, Dianne N., BS, Schneiderbauer, Michaela M., MD, MBA, Robinson, Raymond P., MD, and Hernandez, Victor H., MD.
• PDF

45. Long-Term (up to 38 Years) Failure Modes of Total Hip Arthroplasty in Adult Patients Who Had Childhood Infection of Hip

• Pages 1612-1617.
• Kim, Young-Hoo, MD, Park, Jang-Won, MD, Jang, Young-Soo, MD, and Kim, Eun-Jung, MD.
• PDF

46. Opioid and Analgesic Use Before and After Revision Knee Arthroplasty for the Indications “Pain Without Loosening” Versus “Aseptic Loosening” – A Danish Nationwide Study

• Pages 1618-1625.e3.
• Arndt, Kristine Bollerup, MD, Schrøder, Henrik M., MD, PhD, Troelsen, Anders, DMSci, MD, PhD, and Lindberg-Larsen, Martin, MD, PhD.
• PDF

47. Survivorship and Risk Factors for Re-Revision after Aseptic Revision Total Hip Arthroplasty in Patients Aged ≤55 Years

• Pages 1626-1630.
• Sarpong, Nana O., MD, MBA, Kaidi, Austin C., MD, MSc, Syku, Marie, BA, Mensah, Curtis, MS, Blevins, Jason L., MD, and Chalmers, Brian P., MD.
• PDF

48. Does Revision of an Acetabular Shell With Insertion of an Uncemented Constrained Liner Confer Benefit Over Cementing Into a Well-Ingrown Shell?

• Pages 1631-1635.
• Warschawski, Yaniv, MD, Morgan, Samuel, Garceau, Simon P., MD, Kuzyk, Paul R., MD, MASc, FRCSC, Safir, Oleg A., MD, FRCSC, and Gross, Allan E., MD, FRCSC.
• PDF

49. Surgical Helmets Used During Total Joint Arthroplasty Harbor Common Pathogens: A Cautionary Note

• Pages 1636-1639.
• Tarabichi, Saad, MD, Chisari, Emanuele, MD, Van Nest, Duncan S., MD, Krueger, Chad A., MD, and Parvizi, Javad, MD, FRCS.
• PDF

50. The Impact of COVID-19 on Total Joint Arthroplasty Fellowship Training

• Pages 1640-1644.e2.
• Silvestre, Jason, MD, Thompson, Terry L., MD, and Nelson, Charles L., MD.
• PDF

51. Examination of Randomized Trials and Corresponding Trial Registry Entries: Registration Timing and Primary Outcome Analysis in the Journal of Arthroplasty

• Pages 1645-1649.e7.
• Riddle, Daniel L., PT, PhD, FAPTA, Goldman, Ashton H., MD, Tarver, Talicia, MLIS, and Patel, Nirav K., MD.
• PDF

52. The Use of Rifampin in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis of Comparative Studies

• Pages 1650-1657.
• Kruse, Colin C., BSc, Ekhtiari, Seper, MD, MSc, Oral, Ismet, MD, Selznick, Asher, BSc, Mundi, Raman, MD, MSc, FRCSC, Chaudhry, Harman, MD, MSc, FRCSC, Pincus, Daniel, MD, PhD, FRCSC, Wolfstadt, Jesse, MD, MSc, FRCSC, and Kandel, Christopher E., MD, FRCPC.
• PDF

53. Minimally Invasive Intermuscular Approaches Versus Conventional Approaches in Total Hip Arthroplasty: A Systematic Review and Meta-Analysis

• Pages 1658-1666.
• Clesham, Kevin, MD, Sheridan, Gerard A., MD, Greidanus, Nelson V., MD, Masri, Bassam A., MD, Garbuz, Donald S., MD, Duncan, Clive P., MD, and Howard, Lisa C., MD.
• PDF

54. Letter to the Editor on “Mepivacaine Versus Bupivacaine Spinal Anesthesia for Primary Total Joint Arthroplasty: A Systematic Review and Meta-Analysis”

• Pages e1-e2.
• Fu, Zhongmin, MD, Tang, Xiumei, MD, and Ning, Ning, PhD.
• PDF

55. Response to Letter to the Editor on “Mepivacaine Versus Bupivacaine Spinal Anesthesia for Primary Total Joint Arthroplasty: A Systematic Review and Meta-Analysis”

• Pages e3-e4.
• Siddiqi, Ahmed, DO, MBA, Mahmoud, Yusuf, MD, Secic, Michelle, MS, Tozzi, John M., MD, Emara, Ahmed, MD, Piuzzi, Nicolas S., MD, Culp, Brian, MD, Schwarzkopf, Ran, MD, MSc, Springer, Bryan D., MD, and Chen, Antonia F., MD, MBA.
• PDF

56. Retraction Notice to “Commercial Synovial Antibody Testing is No Better Than Traditional Culture in Identification of Pathogen(s) Causing Periprosthetic Joint Infection” [The Journal of Arthroplasty 37 (2022) 777-780]

• Pages 1667-1667.
• Siqueira, Marcelo, MD, Chisari, Emanuele, MD, Yacovelli, Steven, MD, Goswami, Karan, MD, Brownfield, Mia, BS, Shohat, Noam, MD, and Parvizi, Javad, MD, FRCS.
• PDF

57. Conflict of Interest Statement

• Pages 1668-1668.
• PDF